Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 1998

View Archived Issues

Northwest Biotherapeutics patents dendritic cell-based immunotherapy for prostate cancer

Androsorb to enter second part of hormone replacement therapy trial

RiboGene and EnzyMed to collaborate on antiinfective drug discovery

American Biogenetic Sciences and the University of Maryland to develop HHV-8 diagnostic test

Unique asthma medication launched in Canada

More alpha2-adrenoceptor agonists in the pipeline at Procter & Gamble

Boehringer Mannheim reports new discovery in cancer research

Targeted Genetics: Q2 1998 highlights

Vical: Q2 1998 highlights

Microencapsulated aspirin is a good alternative for treatment of atherosclerosis

Prolifix and BioFocus to cooperate on cancer drug development

Less incidence of overt heart failure in myocardial infarction patients receiving aspirin

Ciclosporin oral solution dispenser cleared by the FDA for marketing

Aspirin-induced increase in ferritin synthesis prevents oxidative injury in cardiovascular disease

Access signs development agreement with ViroTex for amlexanox formulations

Cheil Jedang discloses PDE IV inhibitors for treating asthma

New anticancer agents discovered at American Cyanamid

Chugai investigates macrolide compounds as prokinetic agents

Novel agents for irritable bowel syndrome in early development at Kyorin

Mylan acquires U.S. marketing rights to Zagam

GeneMedicine receives patent protection for gene delivery technologies

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

PD-165167 shows excellent selectivity for dopamine D4 receptors

Novo Nordisk describes the first nonpeptide competitive glucagon antagonist

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Novartis continues to study DPP IV inhibitors; new lead reported at ACS meeting

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Orphan drug designation granted for thalidomide in KS

FDA approves first vaccine for prevention of rotaviral disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...